Roflumilast
NDC 31722-676, Roflumilast, tablet, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-676
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208213
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-676 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST250 ug/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-676-32 | 31722067632 | 2 BLISTER PACK in 1 CARTON (31722-676-32) / 10 TABLET in 1 BLISTER PACK (31722-676-31) |
| 31722-676-36 | 31722067636 | 1 BLISTER PACK in 1 CARTON (31722-676-36) / 28 TABLET in 1 BLISTER PACK (31722-676-35) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f25a0230-3cf6-4366-bebe-0ea5ff8de5abNADAC price for package 31722067632
GET /v1/drugs/nadac/31722067632NADAC price for package 31722067636
GET /v1/drugs/nadac/31722067636
Use it
Look up 31722-676 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-676 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-676. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.